<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0">
<channel>
	<title>The Viral Truth: Making Sense of HIV/AIDS News</title>
	<link>http://www.thebody.com/content/blogrss/helfand/art53121.html</link>
	<description>Myles is the managing editor of TheBody.com. He has been reporting on HIV/AIDS since 2001.</description>
<image>
		<url>http://www.thebody.com/images/blog/mhelfand_blogbox.gif</url>
		<title>Myles Helfand</title>
		<link>http://www.thebody.com/content/blogrss/helfand/art53121.html</link>
		<width>115</width>
		<height>130</height>
	</image>

<item>
	<title>The Thai HIV Vaccine Trial: Is It a Big Deal or Not?</title>
	<link>http://www.thebody.com/content/blogrss/helfand/art54142.html</link>
	<description><![CDATA[<p>If you're feeling a sense of whiplash over the recent barrage of HIV/AIDS vaccine news, you're not alone: Public reaction to the <a href="/content/art53872.html">results of the RV144 Thai HIV vaccine trial</a> has felt like a roller coaster. </p>

<p>First came the over-the-top headlines <a href="http://www.guardian.co.uk/world/2009/sep/24/hiv-infection-vaccine-aids-breakthrough" target="_blank">hailing the results</a> as a veritable miracle of science. Then came the over-the-top headlines <a href="http://www.guardian.co.uk/lifeandstyle/besttreatments/2009/oct/21/further-doubts-about-hiv-vaccine" target="_blank">calling the results into serious doubt</a>.</p>

<p><a href="http://www.thebody.com/content/blogrss/helfand/art54142.html">Read more ...</a></p>
]]></description>
	<guid>http://www.thebody.com/content/blogrss/helfand/art54142.html</guid>
	<pubDate>Wed, 21 Oct 2009 22:11:33 GMT</pubDate>
</item>	

<item>
	<title>ADAP Coverage Struggling in Many States, Leaving Many HIVers in the Lurch</title>
	<link>http://www.thebody.com/content/blogrss/helfand/art53897.html</link>
	<description><![CDATA[<p>HIV vaccine in Thailand = sexy. HIV treatment access in U.S. = yawn.</p>

<p>That's the lesson we can apparently take away from the news of the past two weeks. On the one hand, you have The Big News of the Year: Heralds throughout the U.S. trumpeted the <a href="http://www.thebody.com/content/art53872.html">story about an almost-sort-of-successful HIV vaccine</a>, despite the fact that even if it <i>does</i> pave the way toward a fully effective anti-AIDS shot, that won't happen for many years.</p>

<p>Meanwhile, largely ignored has been the rapidly deteriorating situation regarding HIV treatment access in the <i>world's richest country</i>, where we seem not to be able to afford to give HIV meds to some of our neediest HIV-positive citizens.</p>

<p><a href="http://www.thebody.com/content/blogrss/helfand/art53897.html">Read more ...</a></p>
]]></description>
	<guid>http://www.thebody.com/content/blogrss/helfand/art53897.html</guid>
	<pubDate>Thu, 1 Oct 2009 14:42:22 GMT</pubDate>
</item>	
	
	
<item>
	<title>25-Year Prison Sentence Vanishes for Man Convicted of Not Disclosing HIV Status</title>
	<link>http://www.thebody.com/content/blogrss/helfand/art53799.html</link>
	<description><![CDATA[<p>Twenty-five years in prison and a lifetime of parole. That's the sentence that was initially handed down to Nick Rhoades, a 34-year-old, HIV-positive man living in Ohio. His crime: <a href="http://www.thebody.com/content/art51841.html">Failing to disclose his HIV status to another man before having sex with him</a>.</p>

<p>The man Rhoades slept with did not become infected with HIV. Nonetheless, when District Court Judge Bradley Harris sentenced Rhoades in May 2009, he gave Rhoades the toughest sentence possible under the law, likening Rhoades' actions to "carrying a concealed weapon." And Rhoades himself basically agreed: He pleaded guilty, after all, and from the beginning expressed remorse for his actions.</p>

<p>Then, on Sept. 11 -- just four months into Rhoades' 25-year sentence --  Judge Harris wiped the whole thing out and gave Rhoades five years of parole. Rhoades was released from prison that very day.</p>

<p>Wait. What? Twenty-five years and lifetime parole becomes five years of parole, end of story?</p>

<p><a href="http://www.thebody.com/content/blogrss/helfand/art53799.html">Read more ...</a></p>
]]></description>
	<guid>http://www.thebody.com/content/blogrss/helfand/art53799.html</guid>
	<pubDate>Wed, 23 Sep 2009 23:04:26 GMT</pubDate>
</item>	

<item>
	<title>How Long Will You Live With HIV? Take Studies With a Grain of Salt</title>
	<link>http://www.thebody.com/content/blogrss/helfand/art53605.html</link>
	<description><![CDATA[<p>"How long will I live?"</p>

<p>It's one of the most pressing, frightening questions facing people with HIV, whether they've been newly diagnosed or have been infected for some time. And like so many other questions in HIV, the answer is frustratingly complex, confusing and ever-changing.</p>

<p>How long will you live with HIV? It depends on <i>who</i> you are. Research suggests that HIVers die sooner if, for instance, they use injection drugs; are coinfected with hepatitis; are depressed; or are pretty much any race and sex other than a white male.</p>

<p><a href="http://www.thebody.com/content/blogrss/helfand/art53605.html">Read more ...</a></p>
]]></description>
	<guid>http://www.thebody.com/content/blogrss/helfand/art53605.html</guid>
	<pubDate>Wed, 9 Sep 2009 21:12:25 GMT</pubDate>
</item>	
	
<item>
	<title>Kaletra and Gemfibrozil (Lopid): A Match Not Made in Lipid Heaven</title>
	<link>http://www.thebody.com/content/blogrss/helfand/art53311.html</link>
	<description><![CDATA[<p>Here's a heads-up for those of you with HIV and high cholesterol/triglycerides: Depending on which HIV meds you're taking, lipid-busting drugs may not work exactly the way they're supposed to.</p>

<p>The latest item to add to your "Oh Great, <i>Another</i> Thing I Need to Keep an Eye On" list comes from the <i>Journal of Acquired Immune Deficiency Syndromes</i>, and it specifically concerns a drug known as gemfibrozil (brand name: Lopid), part of a family of triglyceride-fighting drugs called fibrates. <a href="http://journals.lww.com/jaids/Abstract/publishahead/Gemfibrozil_Concentrations_Are_Significantly.99196.aspx" target="_blank">The study</a> involved eight men and seven women, all of whom were HIV-<i>negative</i>. Here's what happened:</p>

<ul>
<li>The 15 people took a single dose of gemfibrozil.</li>
<li>For the next two weeks, the 15 people took a regular twice-daily dose of Kaletra (lopinavir/ritonavir)</li>
<li>When the two weeks were up, the 15 people took another dose of gemfibrozil.</li>
<li>In all 15 people, gemfibrozil didn't absorb into the blood nearly as much as it's supposed to, meaning it lost at least some of its effectiveness.</li>
<li>Nobody experienced any major side effects.</li>
</ul>]]></description>
	<guid>http://www.thebody.com/content/blogrss/helfand/art53311.html</guid>
	<pubDate>Wed, 19 Aug 2009 20:34:15 GMT</pubDate>
</item>
	
<item>
	<title>HIV (Apparently) Comes From Gorillas: What This Means for the HIV Community</title>
	<link>http://www.thebody.com/content/blogrss/helfand/art53117.html</link>
	<description><![CDATA[<p><img src="http://www.thebody.com/images/blog/FayWray.jpg" alt="Anne Darrow: the Fay Wray edition" width="113" height="163" align="left" hspace="5">Look out! You can get HIV from a gorilla! Somebody <a href="http://www.imdb.com/title/tt0024216/" target=_blank>warn Ann Darrow</a>!</p>
<p>OK, OK, let's all calm down. Yes, scientists have apparently found that <a href="http://www.newscientist.com/article/dn17543-gorilla-hiv-makes-leap-to-humans.html" target=_blank>HIV can make the leap from gorillas into humans</a>. But what does it mean for someone living with HIV -- or even for the human race in general? 
For now, at least, it means pretty much <i>nothing</i> -- unless, of course, you're fascinated by cool (by which I mean nerdy) developments in science.</p>]]></description>
	<guid>http://www.thebody.com/content/blogrss/helfand/art53117.html</guid>
	<pubDate>Wed, 5 Aug 2009 23:13:42 GMT</pubDate>
</item>

	
</channel>
</rss>